Asthma is a common inflammatory airway disease for which the most commonly used
controller medications are inhaled corticosteroids (ICS). Asthma control is difficult to achieve …

Adverse drug events (ADEs) are an increasingly relevant issue for healthcare systems as
they are associated with poorer health outcomes and avoidable misuse of resources. The …

Background Allergic asthma is a long-term disorder of the airways resulting from
overexpression of immunoglobulin E (IgE) in response to environmental allergens. Patients …

BACKGROUND: Omalizumab (trade name Xolair) is approved by the US Food and Drug
Administration for treatment of moderate-to-severe allergic asthma. Given the high …

Background Although indoor environmental conditions can affect pediatric asthmatic
patients, few studies have characterized the effect of building interventions on asthma …

Background As-needed budesonide/formoterol is effective in patients with mild asthma for
whom low-dose inhaled corticosteroid (ICS) maintenance therapy is appropriate. We …

Abstract Background The Global Initiative for Asthma recommends the use of as-needed low-
dose inhaled corticosteroid (ICS)-formoterol as a preferred controller therapy for patients …

Abstract Background In the United States, asthma is the most common chronic disease of
childhood across all socioeconomic classes and is the most frequent cause of …

OBJECTIVE: To define the effects of both parenteral and inhaled corticosteroids on bone
growth in children and the development of osteopenia and osteoporosis in children and …

Background: Cystic fibrosis (CF) patients present an increased risk of osteoporosis, and
increased fracture rate. Several factors have been identified as modulators of bone …